Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
59.84
-0.64 (-1.06%)
At close: Apr 28, 2026, 4:00 PM EDT
59.84
0.00 (0.00%)
After-hours: Apr 28, 2026, 7:00 PM EDT
Haemonetics Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Haemonetics stock have an average target of 84.13, with a low estimate of 70 and a high estimate of 100. The average target predicts an increase of 40.59% from the current stock price of 59.84.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Haemonetics stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 1 | 1 | 1 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 1 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $80 → $70 | Buy | Maintains | $80 → $70 | +16.98% | Apr 13, 2026 |
| Citigroup | Citigroup | Hold Maintains $75 → $70 | Hold | Maintains | $75 → $70 | +16.98% | Mar 11, 2026 |
| Citigroup | Citigroup | Hold Maintains $88 → $75 | Hold | Maintains | $88 → $75 | +25.33% | Feb 6, 2026 |
| Mizuho | Mizuho | Buy Maintains $90 → $80 | Buy | Maintains | $90 → $80 | +33.69% | Feb 6, 2026 |
| Barrington Research | Barrington Research | Buy Maintains $93 → $94 | Buy | Maintains | $93 → $94 | +57.09% | Feb 6, 2026 |
Financial Forecast
Revenue This Year
1.34B
from 1.36B
Decreased by -1.68%
Revenue Next Year
1.41B
from 1.34B
Increased by 5.23%
EPS This Year
5.00
from 3.31
Increased by 50.91%
EPS Next Year
5.30
from 5.00
Increased by 6.05%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.4B | 1.5B | |||
| Avg | 1.3B | 1.4B | |||
| Low | 1.3B | 1.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 2.7% | 10.7% | |||
| Avg | -1.7% | 5.2% | |||
| Low | -5.1% | 1.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 5.23 | 5.82 | |||
| Avg | 5.00 | 5.30 | |||
| Low | 4.83 | 4.42 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 58.0% | 16.4% | |||
| Avg | 50.9% | 6.1% | |||
| Low | 46.0% | -11.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.